IBL HealthCare Limited (PSX:IBLHL)

Market Cap	5.14B
Revenue (ttm)	3.57B
Net Income (ttm)	-38.96M
Shares Out	85.67M
EPS (ttm)	-0.46
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	390,834
Average Volume	1,206,881
Open	61.00
Previous Close	61.05
Day's Range	59.51 - 61.59
52-Week Range	25.80 - 71.00
Beta	0.85
RSI	46.49
Earnings Date	Oct 3, 2025

About United States Steel

IBL HealthCare Limited engages in marketing, selling, and distribution of healthcare and pharmaceutical products in Pakistan. The company offers toddlers, baby cereals, infant formulas, medical and lifestyle nutrition, and speciality nutrition products; hygiene and safety products; consumer health products; and vision care and pharma products. It also provides renal care products, such as hollow fiber dialyzer, tubing sets for hemodialysis, double lumen catheter kits, and disposable AV fistula needles; critical care and anesthesia products, suc...

• Industry: Food & Drug Retailing
• Sector: Consumer Non-Cyclicals
• Founded: 1997
• Employees: 292
• Stock Exchange: Pakistan Stock Exchange
• Ticker Symbol: IBLHL

Financial Performance

In 2024, IBL HealthCare's revenue was 3.60 billion, a decrease of -10.54% compared to the previous year's 4.03 billion. Earnings were 7.56 million, a decrease of -97.55%.